Sage Journals: Discover world-class research

Abstract

Objective:

Patients admitted to hospice are more vulnerable to age-related physiologic changes, polypharmacy, and inappropriate medication use and monitoring. The objective of this study was to characterize the utilization of nonprescription medications in a hospice population.

Methods:

This was a retrospective study designed to characterize nonprescription or over-the-counter medication use in hospice patients. Data for this study were provided by Seasons Hospice & Palliative Care, a national hospice organization with licenses to operate in 19 states and collected from January 1 to December 31, 2016. The most frequently utilized nonprescription medications, therapeutic classes, and the frequency of patients with at least 1 claim within a therapeutic class were summarized.

Results:

The final study population included 62 639 orders representing 15 164 patients. The average age was 79.31 years with a standard deviation of 13.31 years. The average length of stay was 26.80 days with a standard deviation of 44.14 days. The top 5 most common medications were as follows: acetaminophen (25.15%), bisacodyl (21.69%), senna (8.35%), omeprazole (4.51%), and docusate (4.46%). Approximately 13 714 (29.67%) of patients were exposed to analgesics, 13 469 (29.14%) to laxatives, and 3535 (7.65%) to antacids or antigas medications.

Conclusion:

This study highlights numerous opportunities for improvement in the use of nonprescription medications among hospice patients. Reducing the use of nonprescription medications that are ineffective or produce unwanted side effects can contribute to improving the quality of care that patients receive.

Keywords

hospice nonprescription medication overprescribing palliative care humans polypharmacy

Get full access to this article

View all access options for this article.

References

Hanlon

Fillenbaum

Ruby

Gray

Bohannon

. Epidemiology of over-the-counter drug use in community dwelling elderly: United States perspective. Drugs Aging. 2001;18(2):123–131.

McPherson

. Nonprescription drug documentation and nursing knowledge in a home health care population. Consult Pharm. 1989;4:32–36.

National Council on Patient Information and Education. Fact sheet: medicine use and older adults. http://www.mustforseniors.org/facts.jsp. Published 2010. Accessed July 7, 2019.

O’Leary

Pawasauskas

Brothers

. Adverse drug reactions in palliative care. J Pain Palliat Care Pharmacother. 2018;32(2-3):98–105.

Legler

Bradley

Carlson

MDA

. The effect of comorbidity burden on health care utilization for patients with cancer using hospice. J Palliat Med. 2011;14(6):751–756.

Maddison

Fisher

Johnston

. Preventive medication use among persons with limited life expectancy. Prog Palliat Care. 2011;19(1):15–21.

National Coalition for Hospice and Palliative Care. Clinical Practice Guidelines for Quality Palliative Care. 4th ed. Richmond, VA. 2018. https://www.nationalcoalitionhpc.org/wp-content/uploads/2018/10/NCHPC-NCPGuidelines_4thED_web_FINAL.pdf. Accessed June 24, 2019.

Center for Medicare and Medicaid Services. Medicare and Medicaid Programs: Hospice Conditions of Participation. Federal Register—The Daily Journal of the United States Government. 2008. https://www.federalregister.gov/documents/2008/06/05/08-1305/medicare-and-medicaid-programs-hospice-conditions-of-participation. Accessed August 14, 2019.

Qato

Alexander

Conti

Johnson

Schumm

Lindau

. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA. 2008;300(24):2867–2878.

10.

Tolkien

Stecher

Mander

Pereira

DIA

Powell

. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383.

11.

Yadlapati

Kahrilas

. When is proton pump inhibitor use appropriate? BMC Med. 2017;15(1):36.

12.

Scarpignato

Gatta

Zullo

Blandizzi

. Effective and safe proton pump inhibitor therapy in acid-related diseases—a position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14(1):179.

13.

Chan

. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(5):483–490.

14.

Lazarus

Chen

Wilson

, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176(2):238–246.

15.

Fakheri

Volpicelli

. Things we do for no reason: prescribing docusate for constipation in hospitalized adults. J Hosp Med. 2019;14(2):110–113.

16.

Tarumi

Wilson

Szafran

Spooner

. Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manage. 2013;45(1):2–13.

17.

Levinson

. Medicare Could Be Paying Twice for Prescription Drugs for Beneficiaries in Hospice. Washington, DC: Department of Health and Human Services; 2012. https://oig.hhs.gov/oas/reports/region6/61000059.pdf. Accessed July 11, 2019.

18.

Kemp

Narula

McPherson

Zuckerman

. Medication reconciliation in hospice: a pilot study. Am J Hosp Palliat Care. 2009;26(3):193–199.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.16 MB

Nonprescription Medication Use in Hospice Patients